Asato Morita

Title: Asato Morita: Innovator in Pharmaceutical Chemistry

Introduction

Asato Morita is a notable inventor based in Aichi-ken, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that interact with specific receptors in the human body. His work has implications for various therapeutic applications.

Latest Patents

Morita holds a patent for N-substituted spiropiperidine compounds as ligands for the ORL-1 receptor. This patent describes a compound of the formula or a pharmaceutically acceptable salt, ester, or ether thereof, wherein R through R are independently hydrogen or the like; X and X are independently CH or the like; R is hydrogen or the like; or R and R taken together with three ring atoms of the quinoline ring separating said substituents form a heterocyclic ring. Additionally, R and R are hydrogen or the like or these groups taken together form oxo; and the dotted line represents a single or double bond. These compounds serve as ligands for the ORL-1 receptor and are particularly effective antagonists for said receptor. He has 1 patent to his name.

Career Highlights

Asato Morita is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to engage in cutting-edge research and development in the pharmaceutical sector.

Collaborations

Morita has collaborated with notable colleagues, including Fumitaka Ito and Hiroki Koike. Their combined expertise has contributed to advancements in their field.

Conclusion

Asato Morita's innovative work in pharmaceutical chemistry, particularly with his patent on ORL-1 receptor ligands, showcases his valuable contributions to science and medicine. His collaborations and career at Pfizer further highlight his impact in the industry.